Implementing continuous process and real time release as a supplemental application change of an approved manufacturing product (a Case Study)
|
|
- Roy Robinson
- 7 years ago
- Views:
Transcription
1 Implementing continuous process and real time release as a supplemental application change of an approved manufacturing product (a Case Study) Eric Sanchez, MS Global Technical Services, Director Solids Platform Janssen Ortho, LLC
2 Presentation content The business case for continuous process and real time release Strategic approach for the process transformation Creating a multifunctional team and project management Continuous Process and PAT Development strategy Partnership with academia Project progress status Process development PAT development Line integration and qualification
3 Why pursuing continuous process transformation? It makes sense from many important aspects of a pharmaceutical production! A continuous process greatly improve material handling and is an enabler for JIT and demand pull Move to Area Move to Area FIFO Weight / Dispense Kanban Move to Area Weight / Dispense Delumping/ Milling Blending Multiple Areas and Handoffs FIFO Move to Area One Room, No Handoffs Move to Area Move to Area FIFO Packaging Kanban Tablet Coating Tablet Compression
4 Continuous Process and Real Time Release Business Case A quantum leap in process knowledge Quality and Savings Source Batch process Continuous Testing In-process tests & release tests with a cycle time of +30 days On line, at line tests: Cycle time of 5 days Smaller Footprint 7 rooms, 6 discrete pieces of equipment, 80% cost reduction 2 room, 1 equipment train 60% cost reduction Waste 3% 1% 66% yield improvement Capital Investment (for same capacity) $24 MM (est.) $12.4 MM 50% cost reduction
5 Continuous process Business Case- Reliability of Supply Source Current Future Mfg cycle time (dispensing thru coating) 13 days/1000 kg 1.1 days/1000 kg > 90% reduction Release 30+ days 5 days >80% reduction Flexibility of Supply Batch size changes require exp and validation batches No scale up/down Quality control Process Knowledge and controls Ca 10 out of 265,000 tablets measured/examined (for a 600 mg batch) Limited based on unit operation and in process control (IPC s) On/at line measurement measures CU directly, assay continuously! Full controls integration with PAT capability provides process information real time with capabilities of advanced process control More informtion than ever
6 Development strategy Industry / Academia / Government collaboration
7 Development strategy Use of ERC resources Raw material characterization Equipment characterization PAT interface development Continuous process DOE Continuous process samples for in vitro dissolution study Spectroscopic methods evaluation and selection NIR calibration method development for blend and tablets Development of dynamic blend sensing requirements and PAT interface development
8 Full application of Quality by Design Principles Risk Assessment DOE proposal Model base control DOE analysis
9 Quality by Design Considerations: Raw Materials Raw materials properties Raw material physical characteristics Materials flow, compressibility, material shear and electrical properties evaluation Safety aspects of materials handling (explosion mitigation)
10 Quality by Design considerations: Feeding Feeding system Feeding systems optional design aspects selection for each raw materials (feeders screw design (size or type), use of screen at outlet spout)
11 Quality by Design Considarations: Feeding Feeding system Feeding adequacy assessment Feeders re-fill strategy Allowable perturbation levels (minor and major components) Effect of material transfer on feeding consistency and materials mass balance Feeders variation filterability (Blender-Feeder relationship)
12 Quality by Design considerations: Blending Blending system Blend system adequacy Selection of Optional blender blade design and configuration Residence time distribution studies Blend transfer and evaluation of blend (IP test and sensing) Blend parametric DoE aspects in design space study e.g, Throughput, Blender RPM
13 Quality by Design Considerations: Compression Tablet compression process Compression control considerations Effect on compression properties with composition variation (compressibility modeling) Residence time distribution studies Design space aspects of compression (e.g. Throughput = compression speed, composition variation, feed frame RPM, compression force and tablet properties)
14 Quality by Design Considerations: Compression Tablet compression IPC Compression IPC considerations IPC design = physical properties, NIR models (Calibration and ID) NIR Model development aspects Demonstrated Intended use: Real time measurement (effect of time and environment on either model predictions = method ruggedness) Final concentration and content uniformity for acceptance (e.g. Demonstrated adequacy of Calibration model precision, intermediate precision, accuracy, statistical similarity and method concordance with HPLC methodology) Final product identity for acceptance (e.g. Foreign material identification, raw material (active and excipients) concentration out of limits)
15 Quality by Design Considerations: Compression Tablet transfer and film coating considerations Tablet relaxation dynamics considerations Time to coat vs Time to expand Design aspects of tablet transfer coordination and integration of tablet transfer elements to allow tablet acceptance/rejection safeguards and relaxation dynamics requirements Film coating process DoE aspects (weight gain, process thermodynamic balance, tablets appearance as a response) Overall DoE considerations (effect on dissolution at variable tablet properties)
16 Quality by Design Considerations: Compression Parametric controls CPP definition, DoE based PAR and Equipment Variation Range definitions Feeders = Scada system controls limits based on DoE and Feeders characterization study results CPP = Rate of Feeding, re-fill levels, screw speed, Blender = DoE blending study, blender speed (RPM) Tablet press = Throughput speed, feed frame speed, compression force, fill depth, in process physical properties (Multivariable control scheme) Coating = Process thermodynamic balance
17 Quality by Design Considerations: Compression Model Based controls (future goal) Use predictive models for control assessment and actions real time Feeders = Fourier transformed on feeders rate variation Blender = Taylor dispersion model, mean center variance on residence time distribution Tablet press = multivariable models, density base models Coating = Process thermodynamic models
18 Process and PAT development status Development milestones achieved Raw material characterization Automated dispensing (feeders) characterization Continuous blending design and characterization NIR PCA identity model and PLS Calibration model for API (blend and tablets) Use of Rutgers pilot line for the selected product Continuous Process Development DOE (Throughput, Blender Speed and configuration, Compression force) In vitro comparability completed, F1 and F2 comparability requirements pass DOE analysis completed 18
19 % LC % LC % LC % LC In vitro comparability results Regulatory Method N HCL f2 75 f f2 99 f Lot: Current 12MG0048 process Lot Run: 0-B Lot. Current 12MG0048 process Lot Run: 0-B M Phophate Buffer ph M Phophate Buffer ph 4.5, 6.5, 6.8 and 7.5 Max F1 = 13 Min F2 = f2 69 f Lot: Current 12MG0048 process Lot Run: 0-B Reference: Phosphate buffer ph 4.5 New Process: Phosphate buffer ph 4.5 Reference: Phosphate Buffer ph 6.5 Reference: Phosphate Buffer ph 6.8 Reference - Phosphate Buffer ph 7.5 New Process - Phosphate Buffer ph 6.5 New Process - Phosphate buffer ph
20 Dissolution Prediction and Controls = Surrogated Dissolution Proposal Dissolution predictive elements Dissolution Control Elements Multivariable thermodynamic control, empirical DS control API API Particle Size (COA) and Concentration control Film coating factors PAT? Disintegrant efficiency Disintegrant moisture and concentration control Multivariate (tablet IP, CPP, IPP) control Compression factors Blend lubrication Blender and feed frame shear control
21 Thanks to the teams!
22 Project status Project milestones achieved (JSC Gurabo facility) Facility construction completed Equipment installation completed Equipment qualification completed Controls design completed Controls testing (SAT on going) DoE design space confirmation on going Next steps Line integration, and PQ Registration lost manufacturing FDA s pre-operational meeting snda submission 22
23 The line at a glance (pre equipment installation)
24 The line at a glance (during equipment installation) Third Level First Level Panoramic View First Level Second Level First Level
Workshop B Control Strategy
ICH-GCG ASEAN Workshop B Control Strategy Jean-Louis ROBERT, Ph.D. National Health Laboratory, Luxembourg Chair-person ICH IWG Q8, Q9, Q10 Kuala Lumpur, 26-28 July 2010 International Conference on Harmonisation
More informationQbD in der Praxis systematisches Vorgehen bei der Entwicklung pharmazeutischer Herstellprozesse. Adrian Funke
QbD in der Praxis systematisches Vorgehen bei der Entwicklung pharmazeutischer Herstellprozesse Adrian Funke Symposium der Fachgruppe Arzneimittelkontrolle / Pharmazeutische Analytik der DPhG Freiburg
More informationMultivariate Chemometric and Statistic Software Role in Process Analytical Technology
Multivariate Chemometric and Statistic Software Role in Process Analytical Technology Camo Software Inc For IFPAC 2007 By Dongsheng Bu and Andrew Chu PAT Definition A system Understand the Process Design
More informationProcess Validation Protocol (Reference: SOP )
Project Name Equipment Manufacturer Process Line/Location Project Number Serial Number Model Number Protocol number [Enter Product Title, Number & Strength] MULTI VITAMIN TABLETS PRODUCT CODE: Name: Position:
More informationTABLET REFORMULATION CASE STUDY. Executive Summary
TABLET REFORMULATION Executive Summary A large European pharmaceutical company contracted Aptuit to reformulate a tablet with existing dosage strengths of 25 mg and 50 mg. The client required smaller strengths
More informationIN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION
IN VITRO BINDING BIOEQUIVALENCE STUDY SUMMARY TABLES AND SAS TRANSPORT FORMATTED TABLES FOR DATASET SUBMISSION I. For Calcium Acetate Drug Products Table I.1 Submission Summary * Drug Product Name Strength(s)
More informationGuideline on Process Validation
1 2 3 4 29 March 2012 EMA/CHMP/CVMP/QWP/70278/2012-Rev1 Committee for Medicinal Products for Human Use (CHMP) Committee for Medicinal Products for Veterinary Use (CVMP) 5 6 Draft Draft Agreed by CHMP /
More informationQuality by Design Approaches to Analytical Methods -- FDA Perspective. Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011
Quality by Design Approaches to Analytical Methods -- FDA Perspective Yubing Tang, Ph.D. FDA/CDER/ONDQA AAPS, Washington DC October 25, 2011 1 Outline What is Quality by Design (QbD) Role of Analytical
More informationGENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES
February 2013 RESTRICTED GENERAL GUIDANCE FOR INSPECTORS ON HOLD-TIME STUDIES DRAFT FOR COMMENT Should you have any comments on the attached text, please send these to Dr Sabine Kopp, Manager, Medicines
More information11.I In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07
In-process control In-process control Authors: Dr. Christian Gausepohl / Paolomi Mukherji / Update 07 Here you will find answers to the following questions: What are the in-process control tasks? Where
More informationWorkshop A Design Space (DS)
Implementation of ICH Q8, Q9, Q10 Workshop A Design Space (DS) International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Disclaimer The information
More informationPerformance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms
Performance Evaluation of Actimask 92S Ibuprofen: A Novel Taste-Masked Ibuprofen for Use in Orally-Dispersible Dosage Forms Author: Brian D. Wilson Background Recently, orally-dispersible dosage forms,
More informationPHARMACEUTICAL DEVELOPMENT
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE PHARMACEUTICAL DEVELOPMENT Q8(R2) Current Step
More informationMultivariate Tools for Modern Pharmaceutical Control FDA Perspective
Multivariate Tools for Modern Pharmaceutical Control FDA Perspective IFPAC Annual Meeting 22 January 2013 Christine M. V. Moore, Ph.D. Acting Director ONDQA/CDER/FDA Outline Introduction to Multivariate
More informationImplementing New USP Chapters for Analytical Method Validation
Implementing New USP Chapters for Analytical Method Validation March 2010 Ludwig Huber Fax.: +49 7243 602 501 E-mail: Ludwig_Huber@labcompliance.com Today s Agenda Handling Method Changes vs. Adjustments
More informationDirectly compressed mini-tablets coated in a solid-wall pan for sustained drug release
Directly compressed mini-tablets coated in a solid-wall pan for sustained drug release March 2012 N. Passerini, B. Albertini, L.Rodriguez Department of Pharmaceutical Sciences, University of Bologna C.
More informationPRODUCT DEVELOPMENT GUIDE
PRODUCT DEVELOPMENT GUIDE PRE-FORMULATION - TABLETS Introduction Guidelines for the development of a ANDA product for the US market, Note: some tests or procedures may be unnecessary. The order of performing
More information2.3 QUALITY OVERALL SUMMARY Sakura Tablet
English Mock QOS P2_Final_June08 MODULE 2: COMMON TECHNICAL DOCUMENT SUMMARIES Generic name: Amokinol 2.3 QUALITY OVERALL SUMMARY Sakura Tablet 1 English Mock QOS P2 Final TABLE OF CONTENTS Page Table
More informationPharmaceutical Quality Systems: US Perspective
Pharmaceutical Quality Systems: US Perspective Rick Friedman Associate Director, Office of Manufacturing and Product Quality Center for Drug Evaluation and Research Topics Background: The ICH Q10 Pharmaceutical
More informationProcess Systems Engineering in Pharmaceutical Development & Manufacture
Process Systems Engineering in Pharmaceutical Development & Manufacture G.V. Rex Reklaitis School of Chemical Engineering Purdue University In Sympathy with Tom Edgar s 65 th Birthday NSF ERC FOR STRUCTURED
More informationCalibration & Preventative Maintenance. Sally Wolfgang Manager, Quality Operations Merck & Co., Inc.
Calibration & Preventative Maintenance Sally Wolfgang Manager, Quality Operations Merck & Co., Inc. Calibration: A comparison of two instruments or measuring devices one of which is a standard of known
More informationVinod et al., ARPB, 2013; Vol 3 (II) ISSN 2250-0774
Vinod et al., ARPB, 2013; Vol 3 (II) ISSN 2250- (RESEARC ARTICLE) QUALIFICATION OF EQUIPMENT: SAIZONER MIXER GRANULATOR, COMPRESSION MACINE AND COATING PAN * J. Vinod and A. Chenthilnathan Department of
More informationQ8(R2): Pharmaceutical Development
ICH-GCG ASEAN Q8(R2): Pharmaceutical Development Jean-Louis ROBERT, Ph.D. National Health Laboratory, Luxembourg Chair-person ICH IWG Q8, Q9, Q10 Kuala Lumpur, 26-28 July 2010 International Conference
More informationValidation and Calibration. Definitions and Terminology
Validation and Calibration Definitions and Terminology ACCEPTANCE CRITERIA: The specifications and acceptance/rejection criteria, such as acceptable quality level and unacceptable quality level, with an
More informationMaking Improvement Work in Pharmaceutical Manufacturing Some Case Studies. Ronald D. Snee
Making Improvement Work in Pharmaceutical Manufacturing Some Case Studies Ronald D. Snee ISPE Midwest Extended Education and Vendor Day Overland Park, KS 2 May 2007 King of Prussia PA New York NY Washington
More informationSTARCH 1500. Application Data
STARCH 1500 Application Data Partially Pregelatinized Maize Starch Starch 1500, Partially Pregelatinized Maize Starch, Used as a Binder Disintegrant in High Shear Wet Granulation Comparison to Povidone
More informationA Preliminary Proposal for a Pharmaceutical Engineering Graduate Program
A Preliminary Proposal for a Pharmaceutical Engineering Graduate Program Planning Committee: Prabir Basu Steve Byrn Ken Morris Rex Reklaitis Paul Sojka Venkat Venkatasubramanian Carl Wassgren National
More informationControl Strategy Case Studies
Control Strategy Case Studies Vance Novack, GSK Workshop on Implementation of ICH Q8/Q9/Q10 and Other Quality Guidelines Beijing, China, Dec 2008 Control Strategy Case Studies The information and knowledge
More informationINTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Review Article INDUSTRIAL PROCESS VALIDATION OF TABLET DOSAGE FORM: AN OVERVIEW Gupta Surbhi 1 *, Saini Seema 1, Singh Gurpreet
More informationICH guideline Q8, Q9 and Q10 - questions and answers volume 4
December 2010 EMA/CHMP/ICH/265145/ Committee for medicinal products for human use (CHMP) ICH guideline Q8, Q9 and Q10 - questions and answers volume 4 Step 5 Transmission to CHMP for information December
More informationQbD Considerations for Analytical Methods - FDA Perspective
QbD Considerations for Analytical Methods - FDA Perspective IFPAC Annual Meeting Baltimore, January 25, 2013 Sharmista Chatterjee, Ph.D. CMC Lead for QbD ONDQA/CDER/FDA Outline Role of analytics in drug
More informationInternational Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com. Int. Res J Pharm. App Sci.
International Research Journal of Pharmaceutical and Applied Sciences Available online at www.irjpas.com Int. Res J Pharm. App Sci., 2012; 2(4):1-16 Research Article Process Validation of Benazepril HCl
More informationMethods for the preparation of the test sample from the laboratory sample (Part 1 Material & Methods) Work Package 6 Task 6.4
Methods for the preparation of the test sample from the laboratory sample (Part 1 Material & Methods) Work Package 6 Task 6.4 Validation of prcen/ts 15413 (WI 343027) Paolo de Zorzi APAT - Italian Environmental
More informationThe importance of normalisation when comparing tablet properties
The importance of normalisation when comparing tablet properties Tablet quality definition The properties of a tablet, both during manufacturing and in vivo, are determined by the properties of the materials
More informationContinuous Granulation and Drying
Continuous Granulation and Drying Collette TM Technologies GEA Pharma Systems GEA Pharma Systems supplies advanced technologies for the processing of Active Pharmaceutical Ingredients (API) for the production
More informationQuality by Design for ANDAs: An Example for Modified Release Dosage Forms
Quality by Design for ANDAs: An Example for Modified Release Dosage Forms Introduction to the Example This is an example pharmaceutical development report illustrating how ANDA applicants can move toward
More informationPROCESS VALIDATION OF TABLETS: AN OVERVIEW
PROCESS VALIDATION OF TABLETS: AN OVERVIEW Vikas Verma 1*, Ujjwal Nautiyal 1, M. Senthil Kumar 1, Chandra Kant 1 1 Department of Pharmacy, Himachal institute of Pharmacy, Paonta Sahib, (H.P), India. ABSTRACT
More informationProcess Validation of Solid Oral Dosage Forms, Part I General Principles
Process Validation of Solid Oral Dosage Forms, Part I General Principles İKEV Meeting June 1, 2001 Scott Bozzone, Ph.D. Quality Operations Cork, Ireland European Commission: European definition 1991 -
More informationB i o s o l u t i o n s
B i o s o l u t i o n s Implementation of pharmatracker TM : A case study Prepared by Ocimum Biosolutions Ocimumbio Solutions August 2006 All rights reserved. 2 B i o s o l u t i o n s an ISO 9001:2000
More informationUTS Extended with visioNIR by Kraemer & Ischi Tablet testing equipment for checking Hardness, Diameter, Thickness, Weight and active pharmaceutical ingredient (API)
Testing T Systems for In-Process Control By Kraemer & Ischi STANDARD DEVICE UTS EXTENDEDD Automatic testing system with VisioNIR MEASURED PARAMETERS WEIGHT Nowadays, batches easily reach sizes of > 1,000,000
More informationEvaluating Current Practices in Shelf Life Estimation
Definition of Evaluating Current Practices in Estimation PQRI Stability Working Group Pat Forenzo Novartis James Schwenke Applied Research Consultants, LLC From ICH Q1E An appropriate approach to retest
More informationAdvancements in continuous tablet coating Jim Marjeram O Hara Technologies
Advancements in continuous tablet coating Jim Marjeram O Hara Technologies 16 October 2008 0 Agenda Background on tablet coating Motivation for continuous processing Current continuous coating capability
More informationContent Uniformity (CU) testing for the 21 st Century: CDER Perspective
Content Uniformity (CU) testing for the 21 st Century: CDER Perspective Richard (Rik) Lostritto, Ph.D. Acting Deputy Office Director for Science and Policy and Biopharmaceutics Lead Office of New Drug
More informationGuidance for Industry
Guidance for Industry Q8, Q9, and Q10 Questions and Answers(R4) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics
More informationInnovative vs Traditional
And in the red corner, introducing the challenger NASDAQ April 4 2011 243.47 $ 1.38 $ 0.58 % 0.07 $ 0.02 $ 39.4 % Technology DVD Digital Streamline Instant Play Internet Access Unlimited Selection No Late
More informationXL 200. Pharmaceutical Rotary Press. For Mid-Range Production
XL 200 Pharmaceutical Rotary Press For Mid-Range Production Innovations Made in Berlin Since 1919 Focus Drives Perfection Specialization is the key. Since 1919, KORSCH has focused on its core competency
More informationOperating Principle of the Sample Positioning Flaps
Test WEIGHT, THICKNESS, DIAMETER (or LENGTH), and HARDNESS of regular tablets, odd shaped tablets (caplets, oblongs etc.) and other solid samples fully automatically. Use the WHT 3ME for the fully automated
More informationStep-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry
Step-by-Step Analytical Methods Validation and Protocol in the Quality System Compliance Industry BY GHULAM A. SHABIR Introduction Methods Validation: Establishing documented evidence that provides a high
More informationGuidance for Industry
Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER)
More informationQUALITY BY DESIGN (QBD) : A COMPLETE REVIEW
Review Article QUALITY BY DESIGN (QBD) : A COMPLETE REVIEW Nishendu P. Nadpara*, Rakshit V. Thumar, Vidhi N. Kalola, Parula B. Patel Department of Quality Assurance, S. J. Thakkar Pharmacy College, Opp.
More informationANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING
ANDA CHECKLIST FOR CTD or ectd FORMAT FOR COMPLETENESS and ACCEPTABILITY of an APPLICATION FOR FILING For More Information on Submission of an ANDA in Electronic Common Technical Document (ectd) Format
More informationSolid dosage forms testing: Disintegration test and tablet friability and hardness
Specialized Laboratory for Drug production (N111049) Instructions Solid dosage forms testing: Disintegration test and tablet friability and hardness Tutor: Ing. Jiří Petrů Study program: Drug synthesis
More informationTESTIMONIAL: Congratulations! Our company s EID Incoming Inspection of AMRESCO-provided products
custom solutions With markets changing so rapidly, AMRESCO is on the front line bringing new technologies and processes so we can deliver solutions that solve our customers problems. TESTIMONIAL: Congratulations!
More informationGeneric drugs are copies of innovator drug products
dx.doi.org/10.14227/dt190412p51 In Vitro Equivalence Studies of Generic Metformin Hydrochloride Tablets and Propranolol Hydrochloride Tablets Under Biowaiver Conditions in Lagos State, Nigeria e-mail:
More informationPost-Approval Change Management: Challenges and Opportunities An FDA Perspective
CMC Workshop From Drug Development to Global Supply to Patients April 15-17, 2013, Washington, DC Post-Approval Change Management: Challenges and Opportunities An FDA Perspective Christine M. V. Moore,
More informationPreparing for the Pre-Approval Inspection What to do Before the FDA Arrives. Barry A. Friedman, Ph.D. Consultant
Preparing for the Pre-Approval Inspection What to do Before the FDA Arrives Barry A. Friedman, Ph.D. Consultant FDA Overview FDA is a consumer protection agency within the Department of Health & Human
More informationContinuous manufacturing moving towards real-time release. Creating innovations for the pharmaceutical industry. siemens.
Continuous manufacturing moving towards real-time release Creating innovations for the pharmaceutical industry siemens.com/pharma Strategic partnership Creative ideas and industry expertise A move to continuous
More informationChapter 11. MRP and JIT
Chapter 11 MRP and JIT (Material Resources Planning and Just In Time) 11.1. MRP Even if MRP can be applied among several production environments, it has been chosen here as a preferential tool for the
More informationAS9100 Quality Manual
Origination Date: August 14, 2009 Document Identifier: Quality Manual Revision Date: 8/5/2015 Revision Level: Q AS 9100 UNCONTROLLED IF PRINTED Page 1 of 17 1 Scope Advanced Companies (Advanced) has established
More informationProcess Analytical Technology (PAT) Capabilities and Implementations under QbD Principles QbD and PAT Department
Process Analytical Technology (PAT) Capabilities and Implementations under QbD Principles QbD and PAT Department K1 Competence Center Initiated by the Federal Ministry of Transport, Innovation & Technology
More informationGuide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval Issues as per USFDA
International Journal of PharmTech Research CODEN (USA): IJPRIF ISSN : 0974-4304 Vol.4, No.1, pp 49-55, Jan-Mar 2012 Guide to Inspections of Tablet Manufacturing Facilities including Pre/Post Approval
More informationThe Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets
OPADRY II Application Data High Performance Film Coating System The Effect of Coating Process Conditions and Coating Formula Type on the Quantity and Location of Water in Film Coated Tablets OBJECTIVES
More informationMulti- and Megavariate Data Analysis
Multi- and Megavariate Data Analysis Basic Principles and Applications Third revised edition L. Eriksson, T. Byrne, E. Johansson, J. Trygg and C. Vikström Chapter 18 Process Analytical Technology (PAT)
More informationHow To Test For Contamination In Large Volume Water
Automated Solid Phase Extraction (SPE) of EPA Method 1694 for Pharmaceuticals and Personal Care Products in Large Volume Water Samples Keywords Application Note ENV0212 This collaboration study was performed
More informationPharmaceutical Rotary Presses. PharmaPress 800. High Speed Double Rotary Press
Pharmaceutical Rotary Presses PharmaPress 800 High Speed Double Rotary Press Highest Output with... The KORSCH PharmaPress 800 is a high capacity, double sided tablet press for fully automated and unattended
More informationGUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 *
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PS/INF 11/2015 1 April 2015 GUIDE TO GOOD MANUFACTURING PRACTICE FOR MEDICINAL PRODUCTS ANNEX 15 * * Entry into force:
More informationInternational GMP Requirements for Quality Control Laboratories and Recomendations for Implementation
International GMP Requirements for Quality Control Laboratories and Recomendations for Implementation Ludwig Huber, Ph.D. ludwig_huber@labcompliance.com Overview GMP requirements for Quality Control laboratories
More informationTable 1. Pure superdisintegrant tablet formulation. Material % w/w Weight (mg) Superdisintegrant 99 277.2 Stearic acid 1 2.
PHARMACEUTICAL TECHNOLOGY REPORT Ashland Specialty Ingredients ashland.com PTR-95 Page 1 of 5 Utility of Polyplasdone as a Tablet Binder Quyen Schwing, Marvin Davis, Divya Tewari, Thomas Dürig Ashland
More informationWelcome Computer System Validation Training Delivered to FDA. ISPE Boston Area Chapter February 20, 2014
Welcome Computer System Validation Training Delivered to FDA ISPE Boston Area Chapter February 20, 2014 1 Background Training Conducted on April 24, 2012 Food & Drug Administration Division of Manufacturing
More informationMethod Development and Validation for Particle Size and Shape Measurements
Method Development and Validation for Particle Size and Shape Measurements Ulf Willén Divisional Product Manager Analytical Imaging Systems Malvern Instruments Ltd, Malvern, UK. FDA guidance: when should
More informationQbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance
QbD Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance Dr Amina Faham (Dow), Dr Liz Meehan (AstraZeneca) ExcipientFest, Amsterdam NL June 24, 2014 What do you understand
More informationWhat is Process Validation?
What is Process Validation? Process Validation is defined as the collection and evaluation of data, from the process design stage throughout production, which establishes scientific evidence that a process
More informationQuality by Design Application and Perspectives for biologicals. K. Ho, CHMP Biologics Working Party
Quality by Design Application and Perspectives for biologicals K. Ho, CHMP Biologics Working Party Pharmaceutical development (Q8) Aim: To design a quality product and a manufacturing process to consistently
More informationDesign of Experiments for Analytical Method Development and Validation
Design of Experiments for Analytical Method Development and Validation Thomas A. Little Ph.D. 2/12/2014 President Thomas A. Little Consulting 12401 N Wildflower Lane Highland, UT 84003 1-925-285-1847 drlittle@dr-tom.com
More informationProcess analytical technology PAT for the life sciences industry
analytical technology PAT for the life sciences industry PAT for life sciences A quality by design (QbD) approach using process analytical technology (PAT) requires more than a collection of analyzers
More informationANALYTICAL METHODS INTERNATIONAL QUALITY SYSTEMS
VALIDATION OF ANALYTICAL METHODS 1 GERT BEUVING INTERNATIONAL PHARMACEUTICAL OPERATIONS TASKS: - Internal auditing - Auditing of suppliers and contract manufacturers - Preparing for and guiding of external
More informationGuidance for Industry
Guidance for Industry Immediate Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls, In Vitro Dissolution Testing, and In Vivo Bioequivalence Documentation
More informationBusiness Process Improvement in Life Sciences Manufacturing through the Integration of Information and Production Management Systems and Automation
Business Process Improvement in Life Sciences Manufacturing through the Integration of Information and Production Management Systems and Automation ANTHONY V SOLLAZO Life Sciences Industry Solutions Manager
More informationSession 6: WHO Prequalification Programme. Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs
Session 6: WHO Prequalification Programme Key Process Steps WHO: Medicines UNFPA: Condoms and IUDs Session adapted from the WHO training workshop on prequalification and the WHO technical briefing seminar
More informationCypExpress 3A4 Catalyzed Conversion of Testosterone (TE) to 6β- Hydroxytestosterone (HT)
TM CASE STUDY CypExpress 3A4 Catalyzed Conversion of to Shuvendu Das, 1 Enrique Martez, 2 and Mani Subramanian 1 1 Center for Biocatalysis and Bioprocessg, University of Iowa 2 Oxford Biomedical Research,
More informationEXTRUDER FEEDING SYSTEMS
EXTRUDER FEEDING SYSTEMS www.kreyenborg-pt.com www.kreyenborg-group.com KREYENBORG GROUP BEST TECHNOLOGY INSIDE! The KREYENBORG GROUP is comprised of the following companies: KREYENBORG GmbH, BKG Bruckmann
More informationGuidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation
Guidance for Industry Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions regarding
More informationProcess Validation: Practical Aspects of the New FDA Guidance
Process Validation: Practical Aspects of the New FDA Guidance ISPE Boston Chapter Meeting April 18, 2013 Rusty Morrison Commissioning Agents, Inc. Objectives / Summary What is Process Validation? Regulatory
More informationReview Article Available online at www.jgtps.com
Review Article Available online at www.jgtps.com A REVIEW ON QUALIFICATION OF AUTOCLAVE, RMG, FBD, CONE BLENDER, TABLET COMPRESSION MACHINE B.Venkateswara Reddy* 1, B.Rasmitha Reddy 1, K.Navaneetha 1,
More informationCase Study Development Assessment Implementation Inspection
Implementation of ICH Q8, Q9, Q10 Development Assessment Implementation Inspection International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
More informationIN-LINE PARTICLE SIZE MEASUREMENTS FOR CEMENT AND OTHER ABRASIVE PROCESS ENVIRONMENTS
IN-LINE PARTICLE SIZE MEASUREMENTS FOR CEMENT AND OTHER ABRASIVE PROCESS ENVIRONMENTS 1998 A.P. Malcolmson Malvern, Inc. 10 Southville Road Southborough, MA D. J. Holve Malvern/Insitec, Inc. 2110 Omega
More informationUniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011
Uniformity of Dosage Units (BP 2011 & USP 34) Ms. Witinee Kongsuk Bureau of Drug and Narcotic Department of Medical Sciences June 14, 2011 1 Outline : Definition Harmonized general chapter USP 34
More informationRevision of The Dissolution Procedure: Development and Validation 1092
Page 1 of 5 STIMULI TO THE REVISION PROCESS Stimuli articles do not necessarily reflect the policies of the USPC or the USP Council of Experts Revision of The Dissolution Procedure: Development and Validation
More informationTableting Punch Performance Can Be Improved With Precision Coatings
Tableting Punch Performance Can Be Improved With Precision Coatings by Arnold H. Deutchman, Ph. D. Director of Research and Development (614) 873-4529 X 114 adeutchman@beamalloy.net Mr. Dale C. Natoli
More informationPrescription drug products stability and expiration dates*
Prescription drug products stability and expiration dates* UTMB/NASA-JSC Aerospace Medicine Grand Rounds Houston, TX October 27, 2009 Mansoor A. Khan, R.Ph., Ph.D. Director, FDA/CDER/Division of Product
More informationIntroducing the Improved MAS DRD "Waterless" Cleaning System for Plastic Film, Flakes and Fibers
PRESS RELEASE - For Immediate Distribution Introducing the Improved MAS DRD "Waterless" Cleaning System for Plastic Film, Flakes and Fibers September 28, 2015 - The Upper Austrian plastics machinery manufacturer
More informationResearch needs in pharmaceutical excipients: implications of a global supply chain
Research needs in pharmaceutical excipients: implications of a global supply chain FY 2015 GDUFA Regulatory Science Initiatives Part 15 Public Meeting June 5, 2015 Silver Spring, MD Stephen W. Hoag, Ph.D.
More informationwhitepaper Impact of Formula- on Pharmaceutical Manufacturers www.aptean.com
whitepaper Impact of Formula- Based ERP Applications on Pharmaceutical Manufacturers WHITEPAPER Essentials for pharmaceutical manufacturers 2 about Whether you re in the process of re-evaluating your existing
More informationWhite paper: FDA Guidance for Industry Update Process Validation
White paper: FDA Guidance for Industry Update Process Validation In January 2011, the FDA released the final version of its long-awaited update to its Process Validation Guidance for Industry. Since then,
More informationFundamentals of Tablet Compression
PHARMACEUTICAL PROCESSES Fundamentals of Tablet Compression Armin H. Gerhardt GLOWIMAGES/GETTY IMAGES Pharmaceutical Processes discusses scientific and technical principles associated with pharmaceutical
More informationDVD-R/CD-R 3503 DVD-R/CD-R 3503. your gateway to the future
DVD-R/CD-R DVD-R/CD-R your gateway to the future 2 DVD-R/CD-R HIGHLIGHTS Highlights DVD-R Very compact high performance production tool for DVD-R and CD-R production Small footprint of only 25 m 2 Low
More informationFlour Milling Process Analysis Get more out of your production with High Resolution in-line analysis. ProFoss. Dedicated Analytical Solutions
Flour Milling Process Analysis Get more out of your production with High Resolution in-line analysis ProFoss Dedicated Analytical Solutions Get a clearer picture of your flour milling production with High
More informationThe ability of a manufacturing process to
Exclusive On-Line Article PHARMACEUTICAL ENGINEERING The Official Magazine of ISPE November/December 2006, Vol. 26 No. 6 The Product Quality Research Institute (PQRI) is collaborative effort between the
More informationCommercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations
Commercial Manufacturing - Qualification & Validation-related GMP Deficiencies and Other Lifecycle Considerations Kevin O Donnell PhD Market Compliance Manager, IMB PDA / FDA Conference Pharmaceutical
More information